|
|
|
|
Elbasvir/Grazoprevir Does Not Worsen Renal Function in Patients
With Hepatitis C Virus Infection and Pre-existing Renal Disease
|
|
|
Reported by Jules Levin
The 26th Conference of the Asian Pacific Association for the Study of the Liver;
February 15-19, 2017; Shanghai, China
Chaudhri E1; Reddy KR2; Roth D3; Bruchfeld A4; Hwang P1; Haber B1; Nguyen B-Y1; Barr E1; Wahl J1; Greaves W1
1Merck & Co., Inc., Kenilworth, NJ, USA; 2Division of Gastroenterology and Hepatology, University of Pennsylvania, Philadelphia, PA, USA; 3Division of Nephrology and Hypertension, University of Miami Miller School of Medicine, Miami, FL, USA; 4Department of Renal Medicine, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden
|
|
|
|
|
|
|